{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:59:20Z","timestamp":1776272360044,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003451","name":"Euskal Herriko Unibertsitatea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004437","name":"European Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012440","name":"Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa","doi-asserted-by":"publisher","award":["BIO20\/CI\/016\/BIOEF"],"award-info":[{"award-number":["BIO20\/CI\/016\/BIOEF"]}],"id":[{"id":"10.13039\/501100012440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015866","name":"Hezkuntza, Hizkuntza Politika Eta Kultura Saila, Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["PRE_2023_1_0035"],"award-info":[{"award-number":["PRE_2023_1_0035"]}],"id":[{"id":"10.13039\/100015866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016067","name":"Fondation Charles-Bruneau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["AP171202019"],"award-info":[{"award-number":["AP171202019"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["IT1559-22"],"award-info":[{"award-number":["IT1559-22"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["2021111028"],"award-info":[{"award-number":["2021111028"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>B-cell Acute Lymphoblastic Leukemia (B-ALL) remains an important cause of cancer-related death in children. Therefore, accurate identification at diagnosis of patients at high risk of relapse is crucial. In this context, long non-coding RNAs (lncRNAs) could be novel candidates with great potential. Hence, the aim of this study was to identify new prognostic biomarkers in pediatric B-ALL through an RNA sequencing (RNA-seq) approach that allows the detailed exploration of a wide range of lncRNAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Total RNA from two cohorts of B-ALL patients (C1 with 50 Spanish patients, and C2 with 72 Canadian patients) was sequenced with a depth of approximately 150\u00a0million paired-reads using Illumina technology. All protein coding and non-coding genes included in lncRNAKB annotation were studied to develop a gene expression-based 5-year Event Free Survival (EFS) prediction model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      First, univariate Cox proportional hazards analyses identified 48 genes significantly associated with higher EFS risk in both cohorts. From these, ALASSO regression selected five genes, all of which are lncRNAs, as the most informative to develop the prediction model, which we have called surviBALL. Stratification of patients into three risk groups according to the surviBALL model revealed significantly poorer EFS in high-risk patients across C1, C2, and the integrated C1\u2009+\u2009C2 cohort (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Validation in an independent cohort of 177 publicly available B-ALL samples confirmed surviBALL\u2019s prediction capacity (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20092.80\u2009\u00d7\u200910\n                      <jats:sup>\u2212\u20094<\/jats:sup>\n                      ) and its independence of both subtype and MRD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that surviBALL has the potential to complement current risk stratification approaches, particularly by identifying patients at high risk of relapse at diagnosis. As a hypothesis-generating proof of concept, this study highlights the promise of more personalized treatment strategies and warrants further validation in independent cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40348-025-00210-3","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T03:44:31Z","timestamp":1762746271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["surviBALL: exploring lncRNA expression at diagnosis for 5-year EFS risk stratification in pediatric B-ALL\u2014a proof of concept"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7418-5616","authenticated-orcid":false,"given":"Unai","family":"Illarregi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6792-7984","authenticated-orcid":false,"given":"Nerea","family":"Bilbao-Aldaiturriaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8679-6868","authenticated-orcid":false,"given":"Angela","family":"Gutierrez-Camino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9553-229X","authenticated-orcid":false,"given":"Ivan","family":"Martinez de Estibariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-9321","authenticated-orcid":false,"given":"Javier","family":"Arzuaga-Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3658-7942","authenticated-orcid":false,"given":"Mireia","family":"Camos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-6973","authenticated-orcid":false,"given":"Manuel","family":"Ramirez-Orellana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5012-0137","authenticated-orcid":false,"given":"Itziar","family":"Astigarraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Richer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-6676","authenticated-orcid":false,"given":"Daniel","family":"Sinnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0098-1908","authenticated-orcid":false,"given":"Idoia","family":"Martin-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5309-3031","authenticated-orcid":false,"given":"Elixabet","family":"Lopez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"11","key":"210_CR1","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10552-015-0657-6","volume":"26","author":"AJ Katz","year":"2015","unstructured":"Katz AJ, Chia VM, Schoonen WM, Kelsh MA (2015) Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden. Cancer Causes Control 26(11):1627\u20131642. https:\/\/doi.org\/10.1007\/s10552-015-0657-6","journal-title":"Cancer Causes Control"},{"issue":"3","key":"210_CR2","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","volume":"20","author":"DT Teachey","year":"2019","unstructured":"Teachey DT, Pui C (2019) Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol 20(3):e142\u2013e154. https:\/\/doi.org\/10.1016\/S1470-2045(19)30031-2","journal-title":"Lancet Oncol"},{"issue":"11","key":"210_CR3","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG (2020) Pediatric acute lymphoblastic leukemia. Haematologica 105(11):2524\u20132539. https:\/\/doi.org\/10.3324\/haematol.2020.247031","journal-title":"Haematologica"},{"issue":"1","key":"210_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","volume":"10","author":"L Pagliaro","year":"2024","unstructured":"Pagliaro L, Chen S, Herranz D et al (2024) Acute lymphoblastic leukaemia. Nat Rev Dis Primers 10(1):41\u2013x. https:\/\/doi.org\/10.1038\/s41572-024-00525-x","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"210_CR5","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"issue":"1","key":"210_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/asheducation-2018.1.137","volume":"2018","author":"KG Roberts","year":"2018","unstructured":"Roberts KG (2018) Genetics and prognosis of ALL in children vs adults. Hematol Am Soc Hematol Educ Program 2018(1):137\u2013145. https:\/\/doi.org\/10.1182\/asheducation-2018.1.137","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"210_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C, Chen L, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"210_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P et al (2023) Long non-coding rnas: Definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24(6):430\u2013447. https:\/\/doi.org\/10.1038\/s41580-022-00566-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"210_CR9","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/JCO.22.01114","volume":"41","author":"JE Farrar","year":"2023","unstructured":"Farrar JE, Smith JL, Othus M et al (2023) Long noncoding RNA expression independently predicts outcome in pediatric acute myeloid leukemia. J Clin Oncol 41(16):2949\u20132962. https:\/\/doi.org\/10.1200\/JCO.22.01114","journal-title":"J Clin Oncol"},{"issue":"5","key":"210_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/ijo.2022.5348","volume":"60","author":"U Illarregi","year":"2022","unstructured":"Illarregi U, Telleria J, Bilbao-Aldaiturriaga N et al (2022) LncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review. Int J Oncol 60(5):59. https:\/\/doi.org\/10.3892\/ijo.2022.5348Epub 2022 Apr 8","journal-title":"Int J Oncol"},{"key":"210_CR11","unstructured":"The results published here are in whole or part based upon data generated by the Therapeutically Applicable Research to Generate Effective Treatments (https:\/\/www.cancer.gov\/ccg\/research\/genome-sequencing\/target) initiative, phs000218. The data used for this analysis are available at the Genomic Data Commons (https:\/\/portal.gdc.cancer.gov)"},{"issue":"4","key":"210_CR12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1182\/bloodadvances.2021005634","volume":"6","author":"TH Tran","year":"2022","unstructured":"Tran TH, Langlois S, Meloche C et al (2022) Whole-transcriptome analysis in acute lymphoblastic leukemia: A report from the DFCI ALL consortium protocol 16\u2009\u2013\u2009001. Blood Adv 6(4):1329\u20131341. https:\/\/doi.org\/10.1182\/bloodadvances.2021005634","journal-title":"Blood Adv"},{"issue":"3","key":"210_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig S, Ellermann J, Walther T et al (2021) Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res 31(3):448\u2013460. https:\/\/doi.org\/10.1101\/gr.257246.119","journal-title":"Genome Res"},{"issue":"1","key":"210_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"key":"210_CR15","unstructured":"R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/"},{"issue":"1","key":"210_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41597-020-00659-z","volume":"7","author":"F Seifuddin","year":"2020","unstructured":"Seifuddin F, Singh K, Suresh A et al (2020) lncRNAKB, a knowledgebase of tissue-specific functional annotation and trait association of long noncoding RNA. Sci Data 7(1):326\u2013z. https:\/\/doi.org\/10.1038\/s41597-020-00659-z","journal-title":"Sci Data"},{"issue":"8","key":"210_CR17","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Smyth GK, Shi W (2019) The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res 47(8):e47. https:\/\/doi.org\/10.1093\/nar\/gkz114","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"210_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD (2012) The Sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28(6):882\u2013883. https:\/\/doi.org\/10.1093\/bioinformatics\/bts034","journal-title":"Bioinformatics"},{"issue":"12","key":"210_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550\u2013558. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"issue":"476","key":"210_CR20","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1198\/016214506000000735","volume":"101","author":"H Zou","year":"2006","unstructured":"Zou H (2006) The adaptive Lasso and its oracle properties. J Am Stat Assoc 101(476):1418. https:\/\/doi.org\/10.1198\/016214506000000735","journal-title":"J Am Stat Assoc"},{"key":"210_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the Cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsh PM (2000) Modeling survival data: extending the Cox model. Springer, New York"},{"issue":"1","key":"210_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/M22-0844","volume":"176","author":"DJ McLernon","year":"2023","unstructured":"McLernon DJ, Giardiello D, Van Calster B et al (2023) Assessing performance and clinical usefulness in prediction models with survival outcomes: practical guidance for Cox proportional hazards models. Ann Intern Med 176(1):105\u2013114. https:\/\/doi.org\/10.7326\/M22-0844","journal-title":"Ann Intern Med"},{"issue":"6","key":"210_CR23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1101\/gr.1910904","volume":"14","author":"HK Lee","year":"2004","unstructured":"Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P (2004) Coexpression analysis of human genes across many microarray data sets. Genome Res 14(6):1085\u20131094. https:\/\/doi.org\/10.1101\/gr.1910904","journal-title":"Genome Res"},{"issue":"Database issue","key":"210_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/nar\/gkn698","volume":"37","author":"A Kamburov","year":"2009","unstructured":"Kamburov A, Wierling C, Lehrach H, Herwig R (2009) ConsensusPathDB\u2013a database for integrating human functional interaction networks. Nucleic Acids Res 37(Database issue):623. https:\/\/doi.org\/10.1093\/nar\/gkn698","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"210_CR25","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1002\/cam4.2518","volume":"8","author":"J Zheng","year":"2019","unstructured":"Zheng J, Song Y, Li Z, Tang A, Fei Y, He W (2019) The implication of LncRNA expression pattern and potential function of LncRNA RP4-576H24.2 in acute myeloid leukemia. Cancer Med 8(17):7143\u20137160. https:\/\/doi.org\/10.1002\/cam4.2518","journal-title":"Cancer Med"},{"issue":"3","key":"210_CR26","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.1080\/21655979.2022.2047400","volume":"13","author":"F Qi","year":"2022","unstructured":"Qi F, Tang J, Cai Z, Wang G, Wang Z (2022) Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition (EMT) pathway. Bioengineered 13(3):7592\u20137606. https:\/\/doi.org\/10.1080\/21655979.2022.2047400","journal-title":"Bioengineered"},{"issue":"3","key":"210_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1158\/0008-5472.CAN-18-1617","volume":"79","author":"P Takam Kamga","year":"2019","unstructured":"Takam Kamga P, Dal Collo G, Midolo M et al (2019) Inhibition of Notch signaling enhances chemosensitivity in B-cell precursor acute lymphoblastic leukemia. Cancer Res 79(3):639\u2013649. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1617","journal-title":"Cancer Res"},{"issue":"11","key":"210_CR28","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.exphem.2016.07.012","volume":"44","author":"I Laverdiere","year":"2016","unstructured":"Laverdiere I, Boileau M, Herold T et al (2016) Complement cascade gene expression defines novel prognostic subgroups of acute myeloid leukemia. Exp Hematol 44(11):1039\u20131043e10. https:\/\/doi.org\/10.1016\/j.exphem.2016.07.012","journal-title":"Exp Hematol"},{"issue":"12","key":"210_CR29","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41375-024-02419-z","volume":"38","author":"L Martinez-Verbo","year":"2024","unstructured":"Martinez-Verbo L, Veselinova Y, Llinas-Arias P et al (2024) PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma. Leukemia 38(12):2722\u20132726. https:\/\/doi.org\/10.1038\/s41375-024-02419-z","journal-title":"Leukemia"},{"key":"210_CR30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41375-025-02565-y","volume":"39","author":"J Geyer","year":"2025","unstructured":"Geyer J, Opoku KB, Lin J et al (2025) Real-time genomic characterization of pediatric acute leukemia using adaptive sampling. Leukemia 39:1069\u20131077. https:\/\/doi.org\/10.1038\/s41375-025-02565-y","journal-title":"Leukemia"}],"container-title":["Molecular and Cellular Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-025-00210-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40348-025-00210-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-025-00210-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:19:21Z","timestamp":1762881561000},"score":1,"resource":{"primary":{"URL":"https:\/\/molcellped.springeropen.com\/articles\/10.1186\/s40348-025-00210-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["210"],"URL":"https:\/\/doi.org\/10.1186\/s40348-025-00210-3","relation":{},"ISSN":["2194-7791"],"issn-type":[{"value":"2194-7791","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committees of the CEIm-E (Comit\u00e9 de \u00e9tica para la investigaci\u00f3n de medicamentos de Euskadi) (PI2018101) and CHU Sainte-Justine (QcALL 1993-21, 620). Written informed consent was obtained from all participants and their parents or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}